China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

Chief executive David Zaccardelli said Ohtuvayre was off to an "exceptionally strong start" with more than 3,500 healthcare ...

Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent, tissue-targeted medicines, today announced the appointment of Glenn D. Crater, MD, as chief medical officer (CMO) ...

The global pediatric vaccine market is set for unprecedented growth, with a valuation of US$ 54,130.1 million in 2023, ...

The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...

Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies ...

The FDA previously designated the ADC as a breakthrough drug for relapsed or refractory extensive-stage small-cell lung ...

Which five UK shares does ChatGPT think might be worthy of investment in 2025? Paul Summers reckons one pick might come as a ...

Berenberg Bank analyst Luisa Hector maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.00.

London: GSK plc has announced that the US Food and Drug Administration (USFDA) has granted Breakthrough Therapy Designation ...

GSK announced on Tuesday that its investigational antibody-drug conjugate GSK'227 has been granted breakthrough therapy ...

(Alliance News) - GSK PLC on Tuesday said the US Food & Drug Administration has granted a breakthrough therapy designation to its treatment for a form of bone cancer.